Highlight text to suggest edits
| Disease found: | AIDS Dysmorphic Syndrome |
| Current as of: | October 8, 2024 |
| Disease Overview: | Craniofacial dysmorphism [more info] |
| Signs and Symptoms: | Microcephaly; boxlike forehead; a flattened nasal bridge and shortened nose; and/or philtrum in the center of the upper lip; various eye abnormalities; intrauterine growth retardation, and immunodeficiency. [more info] |
| Diagnosis: | Infants of mothers known to be HIV-positive and/or in infants and children who have certain characteristic symptoms of HIV infection or immune system abnormalities. [more info] |
| Treatment: | Administration of the antiretroviral drug zidovudine (ZDV) by mouth (orally) during the second and third trimesters of pregnancy; intravenously during labor and delivery; and orally to the newborn during the first six weeks of life. [more info] |
| Clinical Management: | Administration of the antiretroviral drug zidovudine (ZDV) by mouth (orally) during the second and third trimesters of pregnancy; intravenously during labor and delivery; and orally to the newborn during the first six weeks of life. [more info] |
| Referral: | ~ 5,000 physicians globally [more info]. Referral to Medical Genetics Department, if available. Initial virtual care is also available through organizations like TeleRare Health. |
| Clinical Trials: | None currently available. [more info] |